CORRIGENDUM: Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing

Detalles Bibliográficos
Autores principales: Suwa, Michihiro, Nohara, Yuki, Morii, Isao, Kino, Masaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Circulation Society 2023
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483109/
https://www.ncbi.nlm.nih.gov/pubmed/37693231
http://dx.doi.org/10.1253/circrep.CR-66-0012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483109/
https://www.ncbi.nlm.nih.gov/pubmed/37693231
http://dx.doi.org/10.1253/circrep.CR-66-0012

Ejemplares similares